These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085 [TBL] [Abstract][Full Text] [Related]
8. [Antidepressants consumption in the global population in France]. Olié JP; Elomari F; Spadone C; Lépine JP Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542 [TBL] [Abstract][Full Text] [Related]
9. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine? Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466 [TBL] [Abstract][Full Text] [Related]
10. Efficacy in long-term treatment of depression. Montgomery SA J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of endogenous depressions with maprotiline, clomipramine, dibenzepine and pyrlindole (author's transl)]. Zapletálek M; Zbytovský J; Libiger J; Pazdírek S; Cápová E Cesk Psychiatr; 1981 Jun; 77(3):198-203. PubMed ID: 6119162 [No Abstract] [Full Text] [Related]
13. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial. Amsterdam JD; Bodkin JA J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814 [TBL] [Abstract][Full Text] [Related]
14. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641 [TBL] [Abstract][Full Text] [Related]
15. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [TBL] [Abstract][Full Text] [Related]
16. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Wade A; Crawford GM; Angus M; Wilson R; Hamilton L Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891 [TBL] [Abstract][Full Text] [Related]
18. [The treatment of severe, therapy-resistant depression using infusions of antidepressants]. Pöldinger W; Dirnhofer-Bertolini E Schweiz Rundsch Med Prax; 1989 Feb; 78(8):188-90. PubMed ID: 2922514 [TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
20. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. Isaac MT; Isaac MB; Gallo F; Tournoux A Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]